DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Determination of Residual Anticoagulatory Effects of Fondaparinux

Information source: Johann Wolfgang Goethe University Hospitals
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Anticoagulant Prophylaxis/Therapy

Phase: N/A

Status: Recruiting

Sponsored by: Johann Wolfgang Goethe University Hospitals

Official(s) and/or principal investigator(s):
Marc Schindewolf, MD, Principal Investigator, Affiliation: J.W. Goethe University Hospital Frankfurt/M.

Overall contact:
Marc Schindewolf, MD, Phone: +49 (0)69 6301, Ext: 5096, Email: marcschindewolf@yahoo.com

Summary

The purpose of this study is to determine residual anticoagulatory effects of a prophylactic or therapeutic fondaparinux treatment i. e. prior to surgery/intervention, after pause of therapy etc.

Clinical Details

Official title: Determination of Residual Anticoagulatory Effects of Prophylactic or Therapeutic Treatment With Fondaparinux

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: antiXa-levels (peak- and through-levels)

Secondary outcome: thromboembolic or bleeding episodes, HIT

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Fondaparinux therapy for at least 3 days

Exclusion Criteria:

- Age < 18 years

- Hemodialysis

Locations and Contacts

Marc Schindewolf, MD, Phone: +49 (0)69 6301, Ext: 5096, Email: marcschindewolf@yahoo.com

J.W. Goethe University Hospital Frankfurt/M., Frankfurt am Main, Hessen 60590, Germany; Recruiting
Marc Schindewolf, MD, Phone: +49 (0)69-6301, Ext: 5096, Email: marcschindewolf@yahoo.com
Edelgard Lindhoff-Last, MD, Phone: +49 (0)69-6301, Ext: 5096, Email: lindhoff-last@em.uni-frankfurt.de
Marc Schindewolf, MD, Principal Investigator
Additional Information

Related publications:

Paolucci F, Frasa H, Van Aarle F, Capdevla A, Clavies MC, van Dinther T, Donat F, Hendriks Y, van den Heuvel M, Nadal T, Lagrange F, Necciari J, Perez Y. Two sensitive and rapid chromogenic assays of fondaparinux sodium (Arixtra) in human plasma and other biological matrices. Clin Lab. 2003;49(9-10):451-60.

Starting date: April 2010
Last updated: April 12, 2010

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017